0.7236
price up icon0.68%   0.0049
after-market 시간 외 거래: .70 -0.0236 -3.26%
loading

Cue Biopharma Inc 주식(CUE)의 최신 뉴스

pulisher
08:43 AM

Reversal indicators forming on Cue Biopharma Inc. stockBond Market & Real-Time Stock Entry Alerts - newser.com

08:43 AM
pulisher
08:29 AM

Is Cue Biopharma Inc. stock a top momentum play2025 Key Lessons & Daily Technical Forecast Reports - newser.com

08:29 AM
pulisher
04:53 AM

Will Cue Biopharma Inc. stock reach all time highs in 2025 - newser.com

04:53 AM
pulisher
04:25 AM

Market reaction to Cue Biopharma Inc.’s recent newsDay Trade & Daily Profit Focused Screening - newser.com

04:25 AM
pulisher
Sep 30, 2025

Is Cue Biopharma Inc. (1UC) stock undervalued after correctionInsider Buying & Real-Time Buy Signal Notifications - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Cue Biopharma names Usman Azam as new CEO and president - The Pharma Letter

Sep 30, 2025
pulisher
Sep 30, 2025

Will breakout in Cue Biopharma Inc. lead to full recoveryTrade Volume Report & Low Risk High Reward Ideas - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Building trade automation scripts for Cue Biopharma Inc.2025 Bull vs Bear & Consistent Income Trade Recommendations - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Cue Biopharma Appoints Usman “Oz” Azam, M.D., as CEO - citybiz

Sep 29, 2025
pulisher
Sep 29, 2025

Cue Biopharma Appoints Usman Azam as New CEO - TipRanks

Sep 29, 2025
pulisher
Sep 29, 2025

How Cue Biopharma Inc. (1UC) stock stacks up against competitorsMarket Performance Report & Fast Gain Swing Trade Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Cue Biopharma, Inc. Appoints Usman ?Oz? Azam, M.D. as President, Effective September 29, 2025 - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

Cue Biopharma appoints new CEO, shifts focus to autoimmune therapies - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

Cue Biopharma names Usman Azam as new CEO, shifts focus to autoimmune disease - Investing.com

Sep 29, 2025
pulisher
Sep 29, 2025

Cue Biopharma appoints Usman Azam as CEO - TipRanks

Sep 29, 2025
pulisher
Sep 29, 2025

Cue Biopharma Announces Strategic Transition in Leadership - GlobeNewswire

Sep 29, 2025
pulisher
Sep 29, 2025

Former Novartis CAR-T Head Takes Helm at Cue Biopharma to Lead Revolutionary Autoimmune Drug Development - Stock Titan

Sep 29, 2025
pulisher
Sep 29, 2025

GC Wealth Management RIA LLC Acquires New Stake in Cue Biopharma, Inc. $CUE - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

How to build a custom watchlist for Cue Biopharma Inc.Weekly Volume Report & Risk Managed Investment Strategies - newser.com

Sep 29, 2025
pulisher
Sep 27, 2025

What drives Cue Biopharma Inc stock priceBull Market Opportunities & Free High Frequency Trading Ideas - Early Times

Sep 27, 2025
pulisher
Sep 27, 2025

Cue Biopharma (NASDAQ:CUE) Trading Up 2.9%What's Next? - MarketBeat

Sep 27, 2025
pulisher
Sep 26, 2025

Cue names Daniel Baker interim CDO, CSO Anish Suri to transition to advisor role - MSN

Sep 26, 2025
$36.32
price up icon 2.95%
$86.70
price up icon 2.23%
$31.77
price up icon 3.59%
$102.21
price up icon 3.64%
$147.28
price up icon 2.27%
biotechnology ONC
$335.16
price down icon 1.63%
자본화:     |  볼륨(24시간):